Sarcoidosis involving most frequently the lungs and skin has been reported in a number of patients with chronic hepatitis C or various malignancies treated with native or pegylated IFNα [121,122] and less frequently in patients treated with IFNβ1. This evidence concerns the gene IFNA1 and sarcoidosis.